|
Synaptic Systems
guinea pig anti app c term Guinea Pig Anti App C Term, supplied by Synaptic Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/app+(c/127+005/bio_rxiv__64898__2026__10__26__761842-136-118-124 Average 94 stars, based on 1 article reviews
guinea pig anti app c term - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Allergan
clinician allergan platysma prominence scale c apps ![]() Clinician Allergan Platysma Prominence Scale C Apps, supplied by Allergan, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/app+(c/allergan+clinician+platysma+prominence+scale/pmc13049361-39-38-39 Average 86 stars, based on 1 article reviews
clinician allergan platysma prominence scale c apps - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
Jackson Laboratory
c intranasal administration app×ps1 transgenic mice ![]() C Intranasal Administration App×Ps1 Transgenic Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/app+(c/app+mice+ps1/us12590130-500-24-35 Average 86 stars, based on 1 article reviews
c intranasal administration app×ps1 transgenic mice - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
Allergan
c apps ![]() C Apps, supplied by Allergan, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/app+(c/allergan+clinician+platysma+prominence+scale/10__1097_slash_prs__0000000000012629-164-0-2 Average 86 stars, based on 1 article reviews
c apps - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
Virtually Better Inc
tough talks for covid-19 vaccine (tt-c) mobile health app-based intervention ![]() Tough Talks For Covid 19 Vaccine (Tt C) Mobile Health App Based Intervention, supplied by Virtually Better Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/app+(c/tough+talks+for+covid+19+vaccine++tt+c++mobile+health+app+based+intervention/pmc12217844-141-28-22 Average 90 stars, based on 1 article reviews
tough talks for covid-19 vaccine (tt-c) mobile health app-based intervention - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Millipore
anti-app c-terminal ![]() Anti App C Terminal, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/app+(c/anti+app+c+terminal+antibody/pm40580389-89-5-9 Average 90 stars, based on 1 article reviews
anti-app c-terminal - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Journal: Journal of Cosmetic Dermatology
Article Title: Patient‐Reported Outcomes After Treatment With OnabotulinumtoxinA for Platysma Prominence: Results From a Phase 2 Dose‐Ranging Study
doi: 10.1111/jocd.70821
Figure Lengend Snippet: Injection sites based on baseline Clinician Allergan Platysma Prominence Scale (C‐APPS) score of grade 3 (left) or grade 4 (right). Reprinted with permission from Rohrich et al. .
Article Snippet: Eligible subjects were adults aged ≥ 18 years with moderate (grade 3) or severe (grade 4) PP at maximum contraction on left and right sides at screening and on day 1 as assessed by the investigator using the
Techniques: Injection
Journal: Journal of Cosmetic Dermatology
Article Title: Patient‐Reported Outcomes After Treatment With OnabotulinumtoxinA for Platysma Prominence: Results From a Phase 2 Dose‐Ranging Study
doi: 10.1111/jocd.70821
Figure Lengend Snippet: Representative images from a 42‐year‐old subject before and after treatment with onabotA. (A) Subject had grade 4 platysma prominence on both sides of the face at baseline based on the C‐APPS. (B) On day 14 after treatment with 36 U of onabotA, the subject achieved a 3‐grade improvement on the C‐APPS on both sides of the face. Reprinted with permission from Rohrich et al. . C‐APPS, Clinician Allergan Platysma Prominence Scale; onabotA, onabotulinumtoxinA.
Article Snippet: Eligible subjects were adults aged ≥ 18 years with moderate (grade 3) or severe (grade 4) PP at maximum contraction on left and right sides at screening and on day 1 as assessed by the investigator using the
Techniques: